HPGC Renmintongtai Pharmaceutical Corp (600829) — Strategic Asset Allocation Index
HPGC Renmintongtai Pharmaceutical Corp (600829) has a Strategic Asset Allocation Index of 13.9% as of June 2023. Strategic assets (PP&E of CN¥363.41 Million plus long-term investments of CN¥-) total CN¥363.41 Million, measured against net assets of CN¥2.62 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
HPGC Renmintongtai Pharmaceutical Corp Strategic Asset Allocation Index (2000–2022)
This chart shows how HPGC Renmintongtai Pharmaceutical Corp's Strategic Asset Allocation Index has evolved across 23 annual periods from 2000 to 2022. As of June 2023, the index stands at 13.9%, representing strategic assets of CN¥363.41 Million against net assets of CN¥2.62 Billion CNY. Explore 600829 cash generation efficiency to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for HPGC Renmintongtai Pharmaceutical Corp (2000–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for HPGC Renmintongtai Pharmaceutical Corp from 2000 to 2022, covering 23 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see HPGC Renmintongtai Pharmaceutical Corp (600829) total market value.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 14.9% | CN¥367.81 Million | CN¥367.81 Million | CN¥- | CN¥2.46 Billion | ▼ -3.7 pp |
| 2021 | 18.7% | CN¥410.84 Million | CN¥410.84 Million | CN¥- | CN¥2.20 Billion | ▲ +3.0 pp |
| 2020 | 15.7% | CN¥312.43 Million | CN¥312.43 Million | CN¥- | CN¥1.99 Billion | ▼ -2.2 pp |
| 2019 | 17.9% | CN¥330.56 Million | CN¥330.56 Million | CN¥- | CN¥1.85 Billion | ▼ -4.0 pp |
| 2018 | 21.9% | CN¥346.13 Million | CN¥346.13 Million | CN¥- | CN¥1.58 Billion | ▼ -1.2 pp |
| 2017 | 23.1% | CN¥372.06 Million | CN¥372.06 Million | CN¥- | CN¥1.61 Billion | ▼ -4.1 pp |
| 2016 | 27.2% | CN¥447.41 Million | CN¥447.41 Million | CN¥- | CN¥1.65 Billion | ▼ -6.1 pp |
| 2015 | 33.3% | CN¥473.56 Million | CN¥473.56 Million | CN¥- | CN¥1.42 Billion | ▼ -17.7 pp |
| 2014 | 51.0% | CN¥1.10 Billion | CN¥1.10 Billion | CN¥- | CN¥2.15 Billion | ▼ -7.3 pp |
| 2013 | 58.3% | CN¥1.32 Billion | CN¥1.32 Billion | CN¥- | CN¥2.26 Billion | ▲ +2.3 pp |
| 2012 | 56.1% | CN¥1.29 Billion | CN¥1.29 Billion | CN¥- | CN¥2.31 Billion | ▼ -9.5 pp |
| 2011 | 65.5% | CN¥1.27 Billion | CN¥1.27 Billion | CN¥- | CN¥1.94 Billion | ▼ -0.6 pp |
| 2010 | 66.2% | CN¥1.15 Billion | CN¥1.15 Billion | CN¥- | CN¥1.74 Billion | ▲ +3.4 pp |
| 2009 | 62.7% | CN¥1.04 Billion | CN¥1.04 Billion | CN¥- | CN¥1.66 Billion | ▲ +5.4 pp |
| 2008 | 57.4% | CN¥945.72 Million | CN¥945.72 Million | CN¥- | CN¥1.65 Billion | ▼ -2.4 pp |
| 2007 | 59.7% | CN¥839.60 Million | CN¥839.60 Million | CN¥- | CN¥1.41 Billion | ▼ -13.1 pp |
| 2006 | 72.8% | CN¥789.09 Million | CN¥789.09 Million | CN¥- | CN¥1.08 Billion | ▼ -7.3 pp |
| 2005 | 80.2% | CN¥712.21 Million | CN¥712.21 Million | CN¥- | CN¥888.23 Million | ▲ +24.2 pp |
| 2004 | 56.0% | CN¥582.51 Million | CN¥582.51 Million | CN¥- | CN¥1.04 Billion | ▼ -59.9 pp |
| 2003 | 115.9% | CN¥649.66 Million | CN¥649.66 Million | CN¥- | CN¥560.39 Million | ▲ +27.3 pp |
| 2002 | 88.6% | CN¥466.16 Million | CN¥466.16 Million | CN¥- | CN¥526.17 Million | ▼ -3.7 pp |
| 2001 | 92.3% | CN¥462.34 Million | CN¥462.34 Million | CN¥- | CN¥501.11 Million | ▼ -5.1 pp |
| 2000 | 97.4% | CN¥454.28 Million | CN¥454.28 Million | CN¥- | CN¥466.36 Million | — |